Pure Global
NCT06050278

Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens

Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens (TAP-NSCLC)
University of Milano Bicocca·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
NSCLC
Drug/Device/Intervention
Tapestry technology
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
University of Milano Bicocca
Location
Monza, Italy
Timeline & enrollment
Phase
N/A
Start date
Apr 03, 2023
End date
Apr 01, 2026
Enrollment
10 participants
Primary outcome

Tapestri success rate

Summary

The goal of this observational study is to evaluate the feasibility of a single cell mutation
 research method in a panel of known oncogenes, using the Tapestri method. Tissue samples will
 be obtained after surgical treatment in patients with I-II-III stage NSCLC.

Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06050278
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06050278 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Milano Bicocca and is currently Recruiting. The study focuses on NSCLC. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.